You are here: Industry Insights > CEO

News List

Ironwood swipes AZ commercial hotshot Mark Mallon to fill its CEO chair fiercepharma
January 08, 2019
Hitting the road this time is Mark Mallon, AstraZeneca’s EVP of global product and portfolio strategy, and he’ll be taking up the CEO baton at newly revamped Ironwood.
Tizona Therapeutics appoints Scott Clarke as CEO biospectrumasia
January 07, 2019
US based biotech company, Tizona Therapeutics has announced that Scott Clarke has joined the company as its chief executive officer. Clarke joins from Roche where he served as the Global Head of Oncology Partnering and Head of Asia 。。。
Ex-Novartis Oncology CEO Liz Barrett joins UroGen fiercebiotech
January 04, 2019
Ex-Novartis Oncology CEO Liz Barrett has joined UroGen Pharma. Barrett is taking over as CEO of the uro-oncology specialist at a time when it is working on a rolling NDA that could lead to its first drug approval.....
Novartis oncology CEO quits after less than a year pharmaphorum
December 21, 2018
Novartis has appointed Susanne Schaffert to lead its oncology division after incumbent CEO Liz Barrett decided to leave for another job.
Pfizer, GSK Form Consumer Healthcare JV contractpharma
December 21, 2018
Pfizer Inc. and GlaxoSmithKline have entered into an agreement to create a global consumer healthcare company with their iconic brands.
STEM Healthcare appoints Jason McKenna as CEO pharmaphorum
December 19, 2018
STEM Healthcare has promoted Jason McKenna (pictured above) to CEO, a role he takes over from the benchmarking company’s co-founder Rob Wood.
Shinichi Tamura re-takes CEO role at Sosei pharmaphorum
December 13, 2018
Sosei has announced that its founder and former CEO Shinichi Tamura will be re-taking the position of CEO as of next year.
Google hires Geisinger CEO as new health strategy leader pharmaphorum
December 12, 2018
Google has hired Geisinger Health CEO David Feinberg to provide strategic leadership as the tech giant moves into the health sector.
Akorn searches for new CEO after failed Fresenius merger pharmaphorum
December 12, 2018
US generics firm Akorn is searching for a new CEO in the wake of a failed merger with Fresenius Kabi last year.Akorn had been set to merge with Fresenius Kabi in 2017...
Executive Moves at Roche contractpharma
December 12, 2018
Daniel O'Day, chief executive officer of Roche Pharmaceuticals and member of the Corporate Executive Committee, will be stepping down from his role as of 31 December 2018.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page